Nombre del producto:Benzoic acid, 4,5-difluoro-2-[[[6-(1H-imidazol-1-yl)-3-pyridazinyl]carbonyl]amino]-, lithium salt (1:1)

IUPAC Name:lithium(1+) 4,5-difluoro-2-[6-(1H-imidazol-1-yl)pyridazine-3-amido]benzoic acid

CAS:2375421-09-1
Fórmula molecular:C15H9F2LiN5O3
Pureza:95%+
Número de catálogo:CM450905
Peso molecular:352.21

Unidad de embalaje Stock disponible Precio($) Cantidad
CM450905-10mg 4-5 Weeks ȤşǠ
CM450905-50mg 5-6 Weeks ȋœœƐ
CM450905-100mg 6-7 Weeks şȋȋƐ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2375421-09-1
Fórmula molecular:C15H9F2LiN5O3
Punto de fusión:-
Código de sonrisas:[Li+].OC(=O)C1=C(NC(=O)c2ccc(nn2)N2C=CN=C2)C=C(F)C(F)=C1
Densidad:
Número de catálogo:CM450905
Peso molecular:352.21
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

Related Products